Why are my triglycerides over 1000?

Triglycerides over 1000 mg/dL indicate severe hypertriglyceridemia, a dangerous condition that requires immediate medical attention to prevent pancreatitis. Common causes include uncontrolled diabetes, genetic disorders, medications, and lifestyle factors.

Questions on this topic?Ask Sai, our AI longevity expert.
Ask Sai

Understanding Severely Elevated Triglycerides

Finding out your triglycerides are over 1000 mg/dL can be alarming, and rightfully so. This level indicates severe hypertriglyceridemia, a serious medical condition that requires immediate attention. Normal triglyceride levels should be below 150 mg/dL, and anything above 500 mg/dL is considered very high. When levels exceed 1000 mg/dL, you're at significant risk for acute pancreatitis, a potentially life-threatening inflammation of the pancreas.

Triglycerides are a type of fat (lipid) found in your blood. When you eat, your body converts calories it doesn't need immediately into triglycerides, which are stored in fat cells and released between meals for energy. However, when this system becomes overwhelmed or dysfunctional, triglycerides can accumulate to dangerous levels in your bloodstream.

Understanding why your triglycerides have reached such extreme levels is crucial for getting appropriate treatment and preventing serious complications. Regular monitoring through comprehensive lipid testing can help track your progress and ensure your treatment plan is working effectively.

Genetic Causes of Severe Hypertriglyceridemia

Genetic testing may be recommended when triglycerides exceed 1000 mg/dL, especially with family history or early onset.
ConditionTypical TG LevelsAge of OnsetKey Features
FCSFamilial Chylomicronemia Syndrome>1500 mg/dLChildhoodLipoprotein lipase deficiency, recurrent pancreatitis
Type IType I Hyperlipoproteinemia>1500 mg/dLInfancy/ChildhoodMilky plasma, eruptive xanthomas, hepatosplenomegaly
Type IVFamilial Hypertriglyceridemia200-1000 mg/dLAdulthoodWorsened by obesity, diabetes, alcohol
Type VMixed Hyperlipidemia1000-10,000 mg/dLAdulthoodCombined elevation of chylomicrons and VLDL

Genetic testing may be recommended when triglycerides exceed 1000 mg/dL, especially with family history or early onset.

Primary Causes of Triglycerides Over 1000

Genetic Disorders

Several inherited conditions can cause severely elevated triglycerides. Familial chylomicronemia syndrome (FCS) is a rare genetic disorder where the body cannot properly break down fats from food. People with FCS lack or have defective lipoprotein lipase, an enzyme essential for breaking down triglycerides. This condition often presents in childhood with triglyceride levels exceeding 1500 mg/dL.

Familial hypertriglyceridemia is another genetic condition that runs in families and causes moderately to severely elevated triglycerides. Unlike FCS, this condition typically manifests in adulthood and may be triggered or worsened by other factors like obesity, diabetes, or alcohol consumption. Understanding your genetic predisposition through family history and specialized testing is essential for proper management.

Uncontrolled Diabetes

Poorly controlled diabetes is one of the most common causes of severely elevated triglycerides. When blood sugar levels remain high, your body becomes less sensitive to insulin, the hormone that helps cells absorb glucose and also plays a crucial role in fat metabolism. This insulin resistance causes the liver to produce more triglycerides while simultaneously reducing the body's ability to clear them from the bloodstream.

The relationship between diabetes and triglycerides creates a dangerous cycle. High triglycerides can worsen insulin resistance, making diabetes harder to control, which in turn drives triglycerides even higher. People with diabetic ketoacidosis or hyperosmolar hyperglycemic state may present with triglycerides well over 1000 mg/dL.

Medication Side Effects

Certain medications can dramatically increase triglyceride levels, especially in susceptible individuals. Oral estrogen therapy, particularly at high doses, can raise triglycerides by 20-50% or more. Retinoids used for acne treatment, beta-blockers for heart conditions, and some HIV protease inhibitors are known to cause significant triglyceride elevation.

Immunosuppressant medications like cyclosporine and sirolimus, often used after organ transplants, can also cause severe hypertriglyceridemia. Antipsychotic medications, particularly second-generation ones like olanzapine and clozapine, may increase triglycerides as part of metabolic syndrome. If you're taking any of these medications, your doctor should monitor your lipid levels regularly.

Secondary Contributing Factors

Lifestyle and Dietary Factors

While lifestyle factors alone rarely push triglycerides over 1000 mg/dL, they can significantly worsen an underlying condition. Excessive alcohol consumption is particularly problematic, as alcohol increases triglyceride production in the liver while impairing the body's ability to clear fats from the blood. Even moderate drinking can cause dramatic spikes in susceptible individuals.

A diet high in refined carbohydrates and added sugars substantially contributes to elevated triglycerides. When you consume more carbohydrates than your body needs, especially simple sugars, your liver converts the excess into triglycerides. Obesity, particularly abdominal obesity, further compounds the problem by promoting insulin resistance and inflammatory processes that interfere with normal fat metabolism.

Medical Conditions

Several medical conditions can contribute to severely elevated triglycerides. Hypothyroidism slows metabolism and reduces the body's ability to clear triglycerides. Kidney disease, particularly nephrotic syndrome, causes protein loss in urine, triggering the liver to overproduce lipids including triglycerides. Cushing's syndrome, characterized by excess cortisol, promotes insulin resistance and triglyceride production.

Pregnancy can also cause significant triglyceride elevation, particularly in the third trimester when levels can increase two to four-fold. While some increase is normal and necessary for fetal development, women with pre-existing hypertriglyceridemia may see dangerous spikes requiring careful monitoring and management.

Immediate Health Risks and Complications

The most immediate and serious risk of triglycerides over 1000 mg/dL is acute pancreatitis. This occurs when excess triglycerides in the blood cause inflammation of the pancreas, leading to severe abdominal pain, nausea, vomiting, and potentially life-threatening complications. The risk of pancreatitis increases exponentially when triglycerides exceed 1000 mg/dL, with some studies showing a 5% risk per year at these levels.

Eruptive xanthomas are another sign of severely elevated triglycerides. These are small, yellow-orange bumps that appear on the skin, typically on the buttocks, shoulders, or extremities. They're caused by triglyceride deposits in the skin and, while not dangerous themselves, indicate dangerously high lipid levels. Lipemia retinalis, a milky appearance of retinal blood vessels visible during eye examination, can also occur and may affect vision.

Long-term complications include accelerated atherosclerosis, increasing the risk of heart attack and stroke. Severely elevated triglycerides can also cause hepatosplenomegaly (enlarged liver and spleen) and may contribute to fatty liver disease. The condition can affect memory and cognitive function, as the brain relies on proper lipid metabolism for optimal function.

Upload your blood test results to track your progress

Seamlessly upload 3rd party biomarker & blood tests to track your whole health in 1 dashboard. Understand what each blood test means and how it fits into the bigger picture of your body and health.

Get diet and lifestyle recommendations based on your blood results, health profile and health goals. You'll also receive a custom supplement recommendation for the precise nutrients your body craves.

Upload Past Blood Test Results

Click or drag file to upload

Once you upload your report, we'll extract the results for your review. Works with top labs including Quest Diagnostics, LabCorp, BioReference, EverlyWell, LetsGetChecked and hundreds of other labs.

Diagnostic Approach and Testing

When triglycerides exceed 1000 mg/dL, your doctor will conduct a comprehensive evaluation to identify the underlying cause. This typically starts with a detailed medical history, including family history of lipid disorders, medication review, and assessment of alcohol consumption and dietary habits. Physical examination may reveal signs like eruptive xanthomas, hepatomegaly, or lipemia retinalis.

Laboratory testing goes beyond basic lipid panels. Your doctor will likely order tests for thyroid function (TSH, Free T4), liver enzymes (ALT, AST), kidney function (creatinine, BUN), and diabetes markers (fasting glucose, HbA1c). Inflammatory markers like high-sensitivity CRP may also be checked. In some cases, genetic testing for familial lipid disorders may be recommended, especially if you have a family history or developed high triglycerides at a young age.

For those interested in comprehensive metabolic monitoring, regular testing can help track how your triglycerides respond to treatment and lifestyle changes. Understanding your complete lipid profile, including advanced markers like ApoB and ApoA1, provides deeper insights into your cardiovascular risk.

Emergency Treatment Strategies

Immediate Medical Interventions

When triglycerides exceed 1000 mg/dL, immediate treatment focuses on rapidly lowering levels to prevent pancreatitis. Initial management often includes hospitalization for close monitoring and aggressive therapy. Intravenous insulin and heparin may be administered to enhance lipoprotein lipase activity and accelerate triglyceride clearance. Some patients may require plasmapheresis, a procedure that filters triglycerides directly from the blood, especially if levels exceed 2000 mg/dL or if pancreatitis has already developed.

Dietary intervention begins immediately with either fasting or a very low-fat diet (less than 10-15 grams per day) until triglycerides drop below 500 mg/dL. All alcohol must be eliminated completely, as even small amounts can trigger dangerous spikes. If diabetes is present, aggressive blood sugar control with insulin therapy becomes essential, as normalizing glucose levels can dramatically reduce triglycerides within days.

Medication Management

Fibrates are typically the first-line medication for severe hypertriglyceridemia, capable of reducing triglycerides by 30-50%. Fenofibrate or gemfibrozil work by activating enzymes that break down triglycerides and reduce liver production of VLDL particles. Omega-3 fatty acids, particularly prescription formulations like icosapent ethyl, can provide additional triglyceride reduction of 20-30% and are often combined with fibrates.

Newer medications show promise for resistant cases. Volanesorsen, an antisense oligonucleotide that reduces apolipoprotein C-III production, can lower triglycerides by up to 70% in patients with familial chylomicronemia syndrome. Statins, while primarily used for cholesterol, may be added once triglycerides are below 500 mg/dL to address overall cardiovascular risk. Your doctor will carefully monitor liver function and adjust medications based on your response and tolerance.

Long-term Management and Prevention

Successfully managing severe hypertriglyceridemia requires a comprehensive, long-term approach combining medication, lifestyle modification, and regular monitoring. Dietary changes form the foundation of management. A diet limiting fat to 10-15% of total calories (about 20-40 grams daily) is often necessary for those with genetic causes. Focus on complex carbohydrates with low glycemic index, lean proteins, and elimination of added sugars and refined grains.

Weight loss, even modest amounts of 5-10% body weight, can significantly improve triglyceride levels and insulin sensitivity. Regular physical activity, aiming for at least 150 minutes of moderate-intensity exercise weekly, helps improve lipid metabolism and glucose control. Stress management techniques like meditation, yoga, or counseling may help, as chronic stress can worsen metabolic dysfunction.

Regular monitoring is essential to prevent recurrence and adjust treatment. Most patients need lipid panels every 4-6 weeks initially, then every 3-6 months once stable. Annual screening for complications including diabetes, liver disease, and cardiovascular disease is recommended. Consider uploading your existing lab results to SiPhox Health's free analysis service for personalized insights and tracking of your progress over time.

Working with Your Healthcare Team

Managing triglycerides over 1000 mg/dL requires a multidisciplinary approach. Your primary care physician will coordinate overall care, but you may also need specialists. An endocrinologist can help manage diabetes and hormonal factors affecting lipid metabolism. A lipid specialist or cardiologist may be necessary for complex cases or when standard treatments fail. A registered dietitian specializing in lipid disorders can create personalized meal plans that are both effective and sustainable.

Communication with your healthcare team is crucial. Report any symptoms immediately, especially abdominal pain, which could indicate pancreatitis. Keep detailed records of your diet, exercise, and any symptom patterns. Be honest about alcohol consumption and medication adherence, as these significantly impact treatment success. Don't hesitate to ask questions about your condition, treatment options, and prognosis.

Support groups and patient organizations can provide valuable resources and emotional support. The National Lipid Association and FCS Foundation offer educational materials and connect patients with similar conditions. Online communities can share practical tips for managing dietary restrictions and navigating insurance coverage for expensive medications.

Taking Control of Your Triglyceride Levels

While triglycerides over 1000 mg/dL represent a serious medical condition requiring immediate attention, with proper treatment and management, most people can achieve significant improvement. The key is addressing both the immediate crisis and underlying causes through a combination of medical intervention, lifestyle modification, and ongoing monitoring. Success requires commitment to treatment plans, regular follow-ups, and patience as your body responds to interventions.

Remember that managing severe hypertriglyceridemia is a marathon, not a sprint. Setbacks may occur, but with persistence and proper medical support, you can reduce your triglycerides to safer levels and significantly lower your risk of complications. Stay engaged with your healthcare team, maintain detailed records of your progress, and celebrate small victories along the way. Your proactive approach to managing this condition can lead to better overall health and quality of life.

References

  1. Berglund L, Brunzell JD, Goldberg AC, et al. Evaluation and treatment of hypertriglyceridemia: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2012;97(9):2969-2989.[PubMed][DOI]
  2. Scherer J, Singh VP, Pitchumoni CS, Yadav D. Issues in hypertriglyceridemic pancreatitis: an update. J Clin Gastroenterol. 2014;48(3):195-203.[PubMed][DOI]
  3. Brahm AJ, Hegele RA. Chylomicronaemia--current diagnosis and future therapies. Nat Rev Endocrinol. 2015;11(6):352-362.[PubMed][DOI]
  4. Sandhu S, Al-Sarraf A, Taraboanta C, Frohlich J, Francis GA. Incidence of pancreatitis, secondary causes, and treatment of patients referred to a specialty lipid clinic with severe hypertriglyceridemia: a retrospective cohort study. Lipids Health Dis. 2011;10:157.[PubMed][DOI]
  5. Valdivielso P, Ramírez-Bueno A, Ewald N. Current knowledge of hypertriglyceridemic pancreatitis. Eur J Intern Med. 2014;25(8):689-694.[PubMed][DOI]
  6. Gaudet D, Brisson D, Tremblay K, et al. Targeting APOC3 in the familial chylomicronemia syndrome. N Engl J Med. 2014;371(23):2200-2206.[PubMed][DOI]

Was this article helpful?

Frequently Asked Questions

How can I test my triglycerides at home?

You can test your triglycerides at home with SiPhox Health's Heart & Metabolic Program. This CLIA-certified program includes triglyceride testing along with comprehensive cardiovascular and metabolic biomarkers, providing lab-quality results from the comfort of your home.

What is considered dangerously high triglycerides?

Triglycerides over 500 mg/dL are considered very high, while levels exceeding 1000 mg/dL are severely elevated and require immediate medical attention due to the high risk of acute pancreatitis. Normal triglycerides should be below 150 mg/dL.

Can triglycerides over 1000 be reversed?

Yes, with proper medical treatment, medication, and lifestyle changes, most people can significantly lower their triglycerides. Treatment typically includes fibrate medications, strict dietary fat restriction, elimination of alcohol, and management of underlying conditions like diabetes.

What foods should I avoid with high triglycerides?

Avoid alcohol completely, limit fats to 10-15% of calories, eliminate added sugars and refined carbohydrates, avoid fried foods, and limit saturated fats from red meat and full-fat dairy. Focus on lean proteins, complex carbohydrates, and vegetables.

How quickly can triglycerides drop with treatment?

With aggressive treatment including medication and dietary changes, triglycerides can drop by 50% or more within days to weeks. However, achieving and maintaining optimal levels typically takes several months of consistent treatment and lifestyle modification.

What are the symptoms of triglycerides over 1000?

Many people have no symptoms, but signs can include abdominal pain (indicating pancreatitis), eruptive xanthomas (yellow skin bumps), milky-appearing blood, enlarged liver or spleen, and in severe cases, memory problems or confusion.

This article is licensed under CC BY 4.0. You are free to share and adapt this material with attribution.

Ask Questions About Any Health Topic

Chat with Sai, our AI health assistant, for personalized insights.

Click or drag file to upload blood test results

Backed By Leading Experts in Health Optimization

Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details